Analyst Price Target is $15.75
▲ +64.41% Upside Potential
This price target is based on 4 analysts offering 12 month price targets for Nobilis Health in the last 3 months. The average price target is $15.75, with a high forecast of $19.00 and a low forecast of $12.00. The average price target represents a 64.41% upside from the last price of $9.58.
Current Consensus is
The current consensus among 4 polled investment analysts is to buy stock in Nobilis Health.
Nobilis Health Corp. owns and manages ambulatory surgical centers (ASCs), and acute-care and surgical hospitals in the United States. It operates through two segments, Medical Services and Marketing. The company's healthcare facilities provides surgical procedures in various clinical specialties, including orthopedic surgery, podiatric, vein and vascular, pain management, gastro- intestinal, gynecology, and general, as well as ear, nose, and throat. It also provides marketing services, patient education services, and patient care co-ordination management services to third party facilities and physicians. As of December 4, 2017, it operated 32 locations, including 5 hospitals, 14 ASCs, and 13 multi-specialty clinics. The company was formerly known as Northstar Healthcare Inc. and changed its name to Nobilis Health Corp. in December 2014. Nobilis Health Corp. was founded in 2007 and is based in Houston, Texas.